Published 2020-09-25
license
Article (before OJS)

Potential Peptide-Based Therapeutic Strategies to Mitigate SARS-COV-2 Infection

DOI: https://doi.org/10.22490/24629448.4187

Authors

Yenny Yolanda Lozano Jiménez Universidad de La Salle
Ruth Mélida Sánchez Mora Universidad Colegio Mayor de Cundinamarca
Sara Emilia Giraldo Quintero Universidad de La Salle.

The new pandemic by SARS-CoV-2 has encouraged the search for therapeutic alternatives that reduce mortality rates; within these, the use of peptides stands out for its ease of synthesis; easy production on a large scale, specificity in the immune response, versatility in dosage, high purity, economy, among others; offering an excellent option to the traditional approach, failing to evaluate its effectiveness, efficiency and safety at clinical level.

keywords: SARS-CoV-2, peptide, therapeutic strategy, vaccine
license

How to Cite

Lozano Jiménez , Y. Y., Sánchez Mora , R. M., & Giraldo Quintero , S. E. (2020). Potential Peptide-Based Therapeutic Strategies to Mitigate SARS-COV-2 Infection. NOVA Biomedical Sciences Journal, 18(35), 61-66. https://doi.org/10.22490/24629448.4187
Almétricas